Filing Details

Accession Number:
0000950170-24-016357
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-16 16:10:07
Reporting Period:
2020-04-01
Accepted Time:
2024-02-16 16:10:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561921 Tela Bio Inc. TELA Surgical & Medical Instruments & Apparatus (3841) 455320061
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746777 Ew Healthcare Partners Fund 2, L.p. 21 Waterway Avenue, Suite 225
The Woodlands TX 77380
No No No No
1746779 Ew Healthcare Partners Fund 2-A, L.p. 21 Waterway Avenue, Suite 225
The Woodlands TX 77380
No No No No
1793943 Ew Healthcare Partners Fund 2 Gp, L.p. 21 Waterway Avenue, Suite 225
The Woodlands TX 77380
No No No No
1793948 Ew Healthcare Partners Fund 2-Ugp, Llc 21 Waterway Avenue, Suite 225
The Woodlands TX 77380
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-01 15,000 $7.47 1,169,231 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-02 15,000 $8.01 1,184,231 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-03 9,634 $8.01 1,193,865 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-06 17,866 $8.10 1,211,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-07 20,000 $8.20 1,231,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-08 15,000 $8.37 1,246,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-09 25,000 $8.47 1,271,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-13 10,000 $7.96 1,281,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-14 15,000 $8.07 1,296,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-15 12,500 $7.99 1,309,231 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-16 17,500 $8.00 1,326,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-17 25,000 $8.25 1,351,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-20 7,000 $8.06 1,358,731 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-21 3,037 $8.32 1,361,768 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-22 10,000 $9.14 1,371,768 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-23 15,000 $9.98 1,386,768 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-04-28 5,000 $9.48 1,391,768 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-07-28 10,000 $12.48 1,401,768 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-07-29 12,600 $12.39 1,414,368 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-07-30 7,400 $12.22 1,421,768 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-07-31 31,825 $11.86 1,453,593 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-08-03 1,400 $11.86 1,454,993 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-08-04 10,200 $12.72 1,465,193 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-08-11 821 $12.95 1,466,014 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-08-14 9,179 $12.95 1,475,193 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-08-28 100 $12.85 1,475,293 No 4 P Indirect See Remarks
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-07-14 5,000 $8.01 3,610,709 No 4 P Indirect See Remarks
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
No 4 P Indirect See Remarks
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.56 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("EW Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A," and together with EW Fund 2, the "EW Funds"), on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
  3. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,917 shares of the amount shown above and EW Fund 2-A purchased 5,717 shares of the amount shown above.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.16 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,265 shares of the amount shown above and EW Fund 2-A purchased 10,601 shares of the amount shown above.
  8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.98 to $8.39 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 8,133 shares of the amount shown above and EW Fund 2-A purchased 11,867 shares of the amount shown above.
  10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.36 to $8.38 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
  12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.35 to $8.58 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  13. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above.
  14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.93 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  15. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
  16. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.09 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  17. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
  18. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.97 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  19. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,083 shares of the amount shown above and EW Fund 2-A purchased 7,417 shares of the amount shown above.
  20. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.99 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  21. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,116 shares of the amount shown above and EW Fund 2-A purchased 10,384 shares of the amount shown above.
  22. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.18 to $8.29 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  23. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above.
  24. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.14 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  25. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,846 shares of the amount shown above and EW Fund 2-A purchased 4,154 shares of the amount shown above.
  26. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,235 shares of the amount shown above and EW Fund 2-A purchased 1,802 shares of the amount shown above.
  27. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.08 to $9.19 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  28. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
  29. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  30. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
  31. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,033 shares of the amount shown above and EW Fund 2-A purchased 2,967 shares of the amount shown above.
  32. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
  33. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.34 to $12.40 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  34. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,124 shares of the amount shown above and EW Fund 2-A purchased 7,476 shares of the amount shown above.
  35. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,009 shares of the amount shown above and EW Fund 2-A purchased 4,391 shares of the amount shown above.
  36. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $12.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  37. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 12,941 shares of the amount shown above and EW Fund 2-A purchased 18,884 shares of the amount shown above.
  38. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 569 shares of the amount shown above and EW Fund 2-A purchased 831 shares of the amount shown above.
  39. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,148 shares of the amount shown above and EW Fund 2-A purchased 6,052 shares of the amount shown above.
  40. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 334 shares of the amount shown above and EW Fund 2-A purchased 487 shares of the amount shown above.
  41. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,732 shares of the amount shown above and EW Fund 2-A purchased 5,447 shares of the amount shown above.
  42. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 41 shares of the amount shown above and EW Fund 2-A purchased 59 shares of the amount shown above.
  43. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,965 shares of the amount shown above and EW Fund 2-A purchased 3,035 shares of the amount shown above.